Les voies innovatrices administration des medicaments et

Les$autres$voies$
d’administration
!"#$%%&#'()*&++&
,-.#/&#0*12&34.%56&"75+1#8(6(9#:-;<5+(9#/&#
9=>%?(%+4@17*7A#&+#,B.CCC#/&#9(#,(<5+(9&4D(+5E%(9&#
FG#%E6&H2"&#IJFK

Objectifs
•'"1357&"#9&7#6E5&7#/=(/H5%57+"(+5E%#<E77529&7#3L&M#9&7#<&"7E%%&7#
<"17&%+(%+#/&#9(#/N7<L(O5&
•'"E<E7&"#/&7#E<+5E%7#+L1"(<&*+5)*&7#%E%#&??"(3+56&7#/(%7#*%#
3E%+&P+&#/&#?5%#/&#65&
•,529&"#9&7#6E5&7#/=(/H5%57+"(+5E%#9&7#<9*7#<&"+5%&%+&7#7&9E%#9&#3E%+&P+&#
395%5)*&

Divulgation$de$conflits$d’intérêts$potentiels
•$*3*%#5%+1"Q+#3E%?953+*&9

Médication$PO$en$fin$de$vie
•CE*6&%+#5H<E77529&#&%#?5%#/&#65&#<E*"#<9*75&*"7#"(57E%7#R
•!N7<L(O5&
•!5H5%*+5E%#/&#9=1+(+#/&#3E%735&%3&
•D(*71&S6EH577&H&%+SE27+"*3+5E%
•BH<E"+(%3&#/&#3E%%(T+"&#/=(*+"&7#6E5&7#/=(/H5%57+"(+5E%#/&7#
H1/53(H&%+7#)*5#7E%+#*+59&7#/(%7#/5??1"&%+7#3E%+&P+&7

Voies$d’administration$de$la$médication
•CE*743*+(%1&#:C,A
•B%+&"H5++&%+
•'&"?*75E%#3E%+5%*&
•U"(%7/&"H5)*&
•V*33E4O5%O56(9&#E*#+"(%74H*)*&*7&#2*33(9&
•B%+"(4"&3+(9&#:BWA
•B%L(9(+5E%
•B%+"(6&5%&*7&#:BXA